Enhancing tuberculosis case notifications through mapping sales of medicine in the private sector: a quasi-experimental study in Punjab province, Pakistan

• Published in: BMC health services research Vol. 25; no. 1; pp. 53 - 12
• Main Authors: Kirubi, Beatrice, Eman, Kinz Ul, Lodhi, Usman R., Fatima, Razia K., Kazi, Ghulam Nabi, Tahmeena, Tahmeena, Shah, Syed Karam, Creswell, Jacob
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 10.01.2025; BioMed Central; BMC
• Subjects: Adolescent; Adult; Antitubercular Agents - economics; Antitubercular Agents - therapeutic use; Case notification; Cost reduction; Disease Notification - statistics & numerical data; Diseases; Documentation; Drug stores; Drug therapy; Drugs; Female; Health surveillance; Humans; Intervention; Male; Mapping; Medical records; Medical research; Medicine, Experimental; Methods; Middle Aged; Pakistan; Pakistan - epidemiology; Pharmacies; Physiological aspects; Prescribing; Private medical care; Private pharmacies; Private provider engagement (PPE); Private Sector; Profits; Prospective Studies; Quasi-experimental methods; Reporting; Sales; Sentinel health events; Testing; Tuberculosis; Tuberculosis - drug therapy; Tuberculosis - epidemiology; Young Adult; Pakistan; Punjab Pakistan; Pakistan; Private provider engagement (PPE); Drug quantification; Mapping; Private pharmacies; Case notification; Private sector
• DOI: 10.1186/s12913-024-12202-6
• ISSN: 1472-6963

In Pakistan, almost one-third of people who develop tuberculosis (TB) are missed by the National TB Program (NTP). A considerable number of people with TB receive treatment in the private sector but remain unnotified. This study documents the outcomes of an intervention to identify people with TB through private pharmacy engagement, building on mapping TB medicine sales in Punjab Province. A comprehensive intervention was carried out in four districts of Punjab with high anti-TB drug sales, comprising a policy change requiring mandatory notification of TB medication sales, mapping and engaging pharmacies selling anti-TB drugs, reporting through a novel 'eTB' mobile application and providing support via a call center. We collected both historical and prospective TB notification data from the intervention and control districts. The primary outcome was the change in TB notifications during the intervention period compared with historical and control notifications. Over the 12-month intervention period, 15,669 people with TB were reported from 2,943 pharmacies in four districts. Among the people identified, 88% were male (n = 13,673), 95% had pulmonary disease (n = 14,969), and 4,256 (27%) were bacteriologically confirmed. Chain pharmacies (n = 14) contributed to 39% of the yield. TB notifications increased by 17,462 (+ 34%) over the baseline period compared with an 8% increase in the control districts. The number of bacteriologically confirmed notifications increased by 32% compared with 16% in the control districts. The proportion of bacteriological confirmation was similar before and during the intervention. The results of the largest TB intervention with pharmacies globally showed incredible potential to link people with TB who are receiving care in the private sector. Mapping TB medicine sales in the private sector with tailored interventions can contribute to closing the gap in notifications where anti-TB drug sales in the private sector are prevalent.